Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAWAN HANI JUMEAN

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1184715435
CMS profile
281328
Location
MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$1,235.88

59 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,119.64 56
Education $116.24 3

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 2; records 51–59 of 59 matching records. This page contains 9 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAWAN HANI JUMEAN

NPI 1184715435 · CMS profile ID 281328

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–59 of 59 matching records. This page contains 9 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1184715435?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAWAN HANI JUMEAN, NPI 1184715435, CMS profile ID 281328. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–59 of 59 matching records. This page contains 9 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1184715435?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). RAWAN HANI JUMEAN, NPI 1184715435, CMS profile ID 281328. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–59 of 59 matching records. This page contains 9 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1184715435?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
RAWAN HANI JUMEAN, NPI 1184715435, CMS profile ID 281328, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–59 of 59 matching records. This page contains 9 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1184715435?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

59 matching records · $1,235.88 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 59 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–59 of 59.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Medtronic, Inc. $16.8603/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815639271 CMS
GENZYME CORPORATION $24.8103/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843563663 CMS
Amgen Inc. $31.1302/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825710737 CMS
GlaxoSmithKline, LLC. $19.5102/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801950905 CMS
UCB, Inc. $17.0302/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807310969 CMS
E.R. Squibb & Sons, L.L.C. $18.6901/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783640723 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $24.8201/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 814986567 CMS
E.R. Squibb & Sons, L.L.C. $20.7901/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783640715 CMS
Amgen Inc. $22.6801/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825710729 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,555.71 56
PY2020 $492.62 18
PY2021 $1,235.88 59
PY2022 $1,763.81 73
PY2023 $1,568.76 68
PY2024 $1,098.66 43
PY2025 $1,113.91 46

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $119,690.54 58
PY2024 Principal investigator $1,184,928.81 53
PY2023 Principal investigator $16,423.46 7
PY2022 Principal investigator $33,733.25 4
PY2020 Principal investigator $9,515.00 1
PY2019 Principal investigator $232,056.13 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

58 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 GlaxoSmithKline, LLC. $2,783.27 11/25/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192153510
Principal investigator 1 GlaxoSmithKline, LLC. $6,115.50 11/07/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192156794
Principal investigator 1 GlaxoSmithKline, LLC. $143.10 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192153523
Principal investigator 1 GlaxoSmithKline, LLC. $133.65 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192155781
Principal investigator 1 GlaxoSmithKline, LLC. $537.30 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192155798
Principal investigator 1 GlaxoSmithKline, LLC. $214.65 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192185376
Principal investigator 1 GlaxoSmithKline, LLC. $214.65 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192185407
Principal investigator 1 GlaxoSmithKline, LLC. $67.50 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192187277
Principal investigator 1 GlaxoSmithKline, LLC. $351.00 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192187280
Principal investigator 1 GlaxoSmithKline, LLC. $64.80 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192187284
Principal investigator 1 GlaxoSmithKline, LLC. $1,097.55 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192187292
Principal investigator 1 GlaxoSmithKline, LLC. $263.25 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192188027
Principal investigator 1 GlaxoSmithKline, LLC. $89.10 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192188035
Principal investigator 1 GlaxoSmithKline, LLC. $214.65 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192188056
Principal investigator 1 GlaxoSmithKline, LLC. $3,013.20 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192189188
Principal investigator 1 GlaxoSmithKline, LLC. $268.65 08/08/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192189196
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192153506
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192153515
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192153520
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192153537
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192155785
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192155789
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192155793
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192156789
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192156820
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192185388
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192185392
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192187300
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192188030
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192188051
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192189180
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192189184
Principal investigator 1 GlaxoSmithKline, LLC. $50.00 06/24/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192189205
Principal investigator 1 GlaxoSmithKline, LLC. $702.00 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192098226
Principal investigator 1 GlaxoSmithKline, LLC. $357.75 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192098232
Principal investigator 1 GlaxoSmithKline, LLC. $2,002.05 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192153529
Principal investigator 1 GlaxoSmithKline, LLC. $129.60 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192153532
Principal investigator 1 GlaxoSmithKline, LLC. $526.50 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192155773
Principal investigator 1 GlaxoSmithKline, LLC. $44.55 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192155777
Principal investigator 1 GlaxoSmithKline, LLC. $1,343.25 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192156787
Principal investigator 1 GlaxoSmithKline, LLC. $311.85 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192156799
Principal investigator 1 GlaxoSmithKline, LLC. $459.00 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192156810
Principal investigator 1 GlaxoSmithKline, LLC. $175.50 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192156814
Principal investigator 1 GlaxoSmithKline, LLC. $286.20 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192185381
Principal investigator 1 GlaxoSmithKline, LLC. $6,180.30 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192185397
Principal investigator 1 GlaxoSmithKline, LLC. $202.50 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192185403
Principal investigator 1 GlaxoSmithKline, LLC. $1,027.35 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192187273
Principal investigator 1 GlaxoSmithKline, LLC. $2,054.70 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192187287
Principal investigator 1 GlaxoSmithKline, LLC. $268.65 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192188039
Principal investigator 1 GlaxoSmithKline, LLC. $89.10 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192188042
Principal investigator 1 GlaxoSmithKline, LLC. $64.80 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192188047
Principal investigator 1 GlaxoSmithKline, LLC. $445.50 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192189192
Principal investigator 1 GlaxoSmithKline, LLC. $194.40 06/06/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192189200
Principal investigator 1 GlaxoSmithKline, LLC. $1,000.00 04/03/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192155769
Principal investigator 1 GlaxoSmithKline, LLC. $1,212.30 04/03/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192156804
Principal investigator 1 GlaxoSmithKline, LLC. $500.00 04/03/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192189176
Principal investigator 1 GlaxoSmithKline, LLC. $2,054.70 02/05/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192187295
Principal investigator 1 GlaxoSmithKline, LLC. $81,636.17 01/28/2025 Non-covered Recipient Entity
NOUVELLE CLINICAL RESEARCH LLC
A MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDI No dispute reported 06/30/2026 1192185372